Results of a diploma study in Biomedical Science in 2013 showed negative staining with CK7 antibody in prostate cancer but positive staining in benign prostate tissue, although this was based on only a few samples. This was suggestive that possibly it could be a good supplement to traditional markers.
Niðurstöður diplómaverkefnis í lífeindafræði 2013 sýndu fram á neikvæða litun mótefnisins CK7 í blöðruhálskirtilskrabbameini en jákvæða litun í góðkynja blöðruhálskirtilsvef sem gaf vísbendingar um að hugsanlega gæti það verið góð viðbót við hefðbundnar mótefnalitanir, en reyndar voru tilfellin fá.